- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00477646
Helping Women Stay Up-To-Date With Cancer Screening By Using a Prevention Care Manager or Usual Care
New York Prevention Care Manager Project / Medicaid Managed Care Organization Version
RATIONALE: Women may stay up-to-date with cancer screening if a health professional helps them overcome barriers to screening, including helping them to schedule cancer screening appointments.
PURPOSE: This randomized clinical trial is studying the use of health professional-tailored telephone support compared with usual care from their personal doctor to help women overcome barriers to screening for colorectal, cervical, and breast cancer.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
OBJECTIVES:
Primary
- Develop and evaluate an enhanced telephone support intervention (Prevention Care Manager [PCM]) to promote colorectal, cervical, and breast cancer screening more widely among women enrolled in a Medicaid Managed Care Organization (MMCO).
- Explore the impact of patient, Community/Migrant Health Center (C/MHC), and MMCO characteristics on cancer screening status and the impact of the intervention.
- Evaluate the impact of the enhanced PCM intervention upon colorectal, breast, and cervical cancer screening rates.
Secondary
- Compare the status of women who are up-to-date (UTD) on CRC screening versus the UTD status of cervical cancer and breast cancer screening.
OUTLINE: This is a randomized, controlled study. The study is conducted in 2 parts.
Part 1 (barrier interview and pilot testing): Patients are stratified according to primary language and whether or not they have had an outpatient visit in the past year.
- Barrier interview: Patients undergo a 15-30 minute interview to determine barriers they face preventing them from receiving recommended cancer screenings and healthcare, as well as facilitators which have encouraged them to be screened.
- Pilot testing: Patients from the barrier interviews and other eligible Medicaid Managed Care Organization (MMCO) patients receive scripted telephone calls from a Prevention Care Manager to assist them in getting up-to-date on their cancer screening tests over 3 months.
Part 2 (randomized control trial): Patients are stratified according to treatment center (Community/Migrant health center vs Diagnostic and Treatment Center) and age. Patient are randomized to 1 of 2 intervention arms.
- Arm I (Prevention Care Manager): Patients are stratified according to the number of tests for which they are up-to-date at baseline. Patients receive reminder letters encouraging them to contact their primary care provider for colorectal, breast, and cervical cancer screening and 3 to 4 telephone support calls to help them become up to date for colorectal, breast, and cervical cancer screening.
- Arm II (usual care): Patients receive usual care according to their primary care physician.
In both arms, patients are followed for 18 months.
PROJECTED ACCRUAL: A total of 2,600 patients will be accrued for this study.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
New York
-
New York, New York, États-Unis, 10018
- Clinical Directors Network, Incorporated
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
DISEASE CHARACTERISTICS:
- Enrolled in a participating Medicaid Managed Care Organization (MMCO) as a Medicaid patient for ≥ 12 months
Not up-to-date (UTD) for colorectal cancer screening
UTD status defined by any of the following:
- Home fecal occult blood test within the past 12 months
- Flexible sigmoidoscopy within the past 5 years
- Double-contrast barium enema within the past 5 years
- Colonoscopy within the past 10 years
- Registered to receive primary care from a participating Community/Migrant Health Center, Diagnostic and Treatment Center, or other participating practice in New York City
- Must have a telephone available
No MMCO claim for any of the following:
- Colorectal, breast, or cervical cancer
- Colon polyp removal
- Total colectomy
PATIENT CHARACTERISTICS:
- Female
- Able to use telephone
- No plans to move for ≥ 1 year
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Prevention Care Management
Telephone support over 18 months from trained Prevention Care Managers, to help women overcome barriers to colon, breast, and cervical cancer screening
|
Telephone support over 18 months to help women become screened for breast, cervical and colon cancer.
Includes barriers assessment, patient education and motivation, provider recommendation letter, appointment reminder, and some scheduling of appointments.
|
Aucune intervention: Usual Care
Usual Care.
A sample of patients receive a single telephone call to validate claims data and collect basic demographic information.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Percentage of patients up-to-date (UTD) for colorectal cancer (CRC) screening
Délai: 18 months
|
Comparison of women in PCM and UC arms who received colon cancer screening tests during 18 month intervention period.
|
18 months
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
Percentage of patients UTD for breast and cervical cancer screening
Délai: 18 months
|
18 months
|
Comparison of UTD status for CRC screening with UTD status for cervical cancer and breast cancer screening
Délai: 18 months
|
18 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Allen J. Dietrich, MD, Norris Cotton Cancer Center
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CDR0000537346
- P30CA023108 (Subvention/contrat des NIH des États-Unis)
- DMS-20253
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Cancer du col de l'utérus
-
Imperial College Healthcare NHS TrustImperial College London; The Wellington Hospital, LondonComplété
-
Duke UniversityNational Cancer Institute (NCI); Jacobi Medical CenterComplété
-
Michigan State UniversityAmerican Osteopathic AssociationComplété
-
Duke UniversityUniversity of ArkansasComplété
-
New York Institute of TechnologyComplété
-
Michigan State UniversityComplété
-
NuVasiveActif, ne recrute pasTrouble discal dégénératif cervicalÉtats-Unis
-
Goethe UniversityComplétéCinématique | Fiabilité | CervicalAllemagne
-
Xin Jiang, MDInconnueBloc du plexus cervical superficielChine
-
National Cancer Institute (NCI)ComplétéPoumon | Sein | Ovaire | Cervical | RénalÉtats-Unis
Essais cliniques sur Prevention Care Management
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ComplétéFibrillation ventriculaire | Tachycardie ventriculaire | Maladie cardiaque congénitale | Décès, Soudain, Cardiaque
-
University of OklahomaRecrutementCancer de la prostate | Comportement de santéÉtats-Unis
-
Silke Wiegand-Grefe, Prof. Dr.Charite University, Berlin, Germany; Hannover Medical School; University Hospital... et autres collaborateursActif, ne recrute pasMaladies raresAllemagne
-
Massachusetts General HospitalCrisis Prevention InstituteComplété
-
AO Clinical Investigation and Publishing DocumentationRésiliéInfection du site opératoireÉtats-Unis, Argentine, Corée, République de, Allemagne, Espagne, Roumanie
-
Medical University InnsbruckBarmherzige Brüder Vienna; Tiroler Landeskrankenanstalten GmbH (TILAK); Tiroler... et autres collaborateursComplétéAccident vasculaire cérébral | Attaque ischémique, transitoire | L'analyse coûts-avantages | Prévention secondaire | Gestion des maladiesL'Autriche
-
Chung Shan Medical UniversityComplétéSoignant | Patient d'AVCTaïwan
-
Johnson & Johnson Vision Care, Inc.ComplétéAcuité visuelle, biomicroscopie à la lampe à fente (évaluation de la coloration cornéenne)États-Unis
-
Elizabeth Glaser Pediatric AIDS FoundationUnited States Agency for International Development (USAID); Ministry of Health...Complété
-
University Hospital, AngersComplétéDouleur thoraciqueFrance, Belgique